HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Wei-Heng Xu Selected Research
Wei-Heng Xu Research Topics
Disease
5
Neoplasms (Cancer)
09/2022 - 10/2016
3
Fibrosis (Cirrhosis)
07/2022 - 08/2014
2
Colitis
09/2022 - 07/2022
2
Sepsis (Septicemia)
06/2022 - 12/2016
2
Hepatocellular Carcinoma (Hepatoma)
01/2017 - 11/2016
2
Liver Neoplasms (Liver Cancer)
01/2017 - 11/2016
1
Dementia (Dementias)
09/2022
1
Ulcerative Colitis
07/2022
1
Disease Progression
07/2022
1
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2022
1
Weight Loss (Weight Reduction)
07/2022
1
Inflammation (Inflammations)
12/2016
1
Endotoxemia
12/2016
1
Liver Cirrhosis (Hepatic Cirrhosis)
08/2014
Drug/Important Bio-Agent (IBA)
3
Matrines
IBA
07/2022 - 11/2016
2
Pharmaceutical Preparations
IBA
09/2022 - 01/2017
2
Dextran Sulfate
IBA
09/2022 - 07/2022
2
matrine derivate masm
IBA
07/2022 - 12/2016
2
Biomarkers (Surrogate Marker)
IBA
06/2022 - 11/2016
1
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
09/2022
1
polydatin
IBA
09/2022
1
Acids
IBA
09/2022
1
cryptotanshinone
IBA
07/2022
1
Collagen
IBA
07/2022
1
Diterpenes
IBA
07/2022
1
Suspensions
IBA
01/2017
1
Alkaloids
IBA
01/2017
1
Messenger RNA (mRNA)
IBA
11/2016
1
Proteins (Proteins, Gene)
FDA Link
11/2016
1
Doxorubicin (Adriamycin)
FDA Link
Generic
11/2016
1
Epithelial Cell Adhesion Molecule
IBA
11/2016
1
Catenins
IBA
11/2016
1
anthracene
IBA
08/2014
1
Thiones
IBA
08/2014
1
ribosomal protein S5
IBA
08/2014
Therapy/Procedure
2
Therapeutics
11/2016 - 10/2016
1
Ligation
12/2016
1
Punctures
12/2016